Real-World Treatment Patterns and Clinical Outcomes Following Chemotherapy and Anti-PD-(L)1 In Non-Small Cell Lung Cancer

被引：0
|
作者：
Velcheti, V. [1 ]
Moore, J. [2 ]
Wang, H. [2 ]
Zhu, X. [2 ]
Samyshkin, Y. [3 ]
Ward, T. [3 ]
Christensen, A. [4 ]
Solem, C. [5 ]
机构：
[1] NYU, Langone Perlmutter Canc Ctr, New York, NY USA
[2] GSK, Collegeville, PA USA
[3] GSK, Brentford, England
[4] GSK, Lakeville, MN USA
[5] GSK, Bethesda, MD USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Real-world; Advanced NSCLC; Treatment Patterns;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.11A.12
引用
收藏
页码：S600 / S601
页数：2
相关论文
共 50 条
  • [1] Real-world treatment patterns and outcomes in PD-L1-positive non-small cell lung cancer
    Zhang, Xinke
    DeClue, Richard W.
    Herms, Lisa
    Yang, Mo
    Pawar, Vivek
    Masters, Elizabeth T.
    Ruisi, Mary
    Chin, Kevin
    Velcheti, Vamsidhar
    IMMUNOTHERAPY, 2021, 13 (18) : 1521 - 1533
  • [2] Real-world treatment patterns and outcomes in US patients (pts) with advanced non-small cell lung cancer (NSCLC) after platinum-based chemotherapy (PBC) and anti-PD-(L)1 treatment
    Velcheti, Vamsidhar
    Moore, Julia
    Wang, Huifen
    Zhu, Xinmei
    Samyshkin, Yevgeniy
    Ward, Thomas
    Christensen, Alena
    Solem, Caitlyn
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Real-world chemotherapy treatment patterns in metastatic non-small cell lung cancer: Are patients undertreated?
    Sacher, Adrian G.
    Le, Lisa W.
    Lau, Anthea
    Earle, Craig C.
    Leighl, Natasha B.
    CANCER, 2015, 121 (15) : 2562 - 2569
  • [4] Immune-Related Adverse Events of Anti-PD-(L)1 Immunotherapy With and Without Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Evidence Study
    Shao, Ping
    Archambault, Alexi N.
    Hampp, Christian
    Sobel, Rachel E. E.
    Asubonteng, Julius
    Geba, Gregory P.
    Pillai, Asha B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 63 - 64
  • [5] Real-World PD-(L)1 Inhibitor Treatment Pattern and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden
    Wagenius, G.
    Vikstrom, A.
    Berglund, A.
    Salomonsson, S.
    Bencina, G.
    Hu, X.
    Chirovsky, D.
    Brunnstrom, H.
    Ekman, S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S380 - S381
  • [6] Treatment patterns and real-world clinical outcomes of metastatic non-small cell lung cancer patients in the immunotherapy era
    Moser, S. Sharman
    Apter, L.
    Arunachalam, A.
    Gazit, S.
    Chodick, G.
    Siegelmann-Danieli, N.
    ANNALS OF ONCOLOGY, 2023, 34
  • [7] Real-World Treatment Patterns and Outcomes for Patients With Advanced Non-Small Cell Lung Cancer in Greece
    Kokkotou, E.
    Charpidou, A.
    Papaspiliou, A.
    Stournara, L.
    Grammatikou, V.
    Ejzykowicz, F.
    Syrigos, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S319 - S319
  • [8] Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors
    Peng Song
    Jingcheng Zhang
    Congcong Shang
    Li Zhang
    Scientific Reports, 9
  • [9] Real-World PD-L1 Testing Patterns for Patients with Advanced Non-Small Cell Lung Cancer in Greece
    Kokkotou, E.
    Charpidou, A.
    Papaspiliou, A.
    Stournara, L.
    Grammatikou, V.
    Ejzykowicz, F.
    Syrigos, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S660 - S660
  • [10] Real-world evidenceand clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors
    Song, Peng
    Zhang, Jingcheng
    Shang, Congcong
    Zhang, Li
    SCIENTIFIC REPORTS, 2019, 9 (1)
12345